Viewing Study NCT07272135


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2025-12-25 @ 8:07 PM
Study NCT ID: NCT07272135
Status: COMPLETED
Last Update Posted: 2025-12-09
First Post: 2022-11-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Selective β2-AR Antagonism in Asthma
Sponsor: Trio Medicines Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module